CoChat

Marked GH secretion after ghrelin alone or combined with GH‐releasing hormone (GHRH) in obese patients

Alvarez‐Castro, Paula, Isidro, Maria Luisa, Garcia‐Buela, Jesús, Leal‐Cerro, Alfonso, Broglio, Fabio, Tassone, Francesco, Ghigo, Ezio, Dieguez, Carlos, Casanueva, Felipe F., Cordido, Fernando · 2004 · Clinical Endocrinology
Cited by 54

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Summary: objectives Ghrelin is a 28‐amino‐acid peptide, predominantly produced by the stomach. It displays a strong GH‐releasing activity mediated by the hypothalamus–pituitary GH secretagogue (GHS)‐receptor (GHS‐R). There are different studies that suggest the importance of ghrelin in feeding and weight homeostasis. In obesity there is a markedly decreased GH secretion. For both children and adults, the greater the body mass index (BMI), the lower the GH response to provocative stimuli, including the response to GHRH. However, the response to the natural GH secretaogogue ghrelin is unclear at the present time. The aim of the present study was to evaluate the GH response to ghrelin alone or combined with GHRH in a group of obese patients, in order to further understand the deranged GH secretory mechanisms in obesity and to clarify the mechanism of action of ghrelin. patients and measurements Six obese female patients (31 ± 3·4 years) with a BMI of 36·1 ± 7·7 kg/m 2 were studied. As a control group, six normal nonobese female subjects of similar age and sex were studied. Four tests were performed: placebo, GHRH [1 µg/kg, no more than 100 µg, intravenous (i.v.)], ghrelin (1 µg/kg, no more than 100 µg, i.v.) and GHRH (1 µg/kg, no more than 100 µg, i.v.) plus ghrelin (1 µg/kg, no more than 100 µg, i.v.). Blood samples were taken at appropriate intervals for determination of GH. Statistical analyses were performed by Wilcoxon and by Mann–Whitney tests. results After GHRH, the median peak GH secretion in obese patients was 2·4 µg/l (range 0·9–8·9 µg/l). Ghrelin‐induced GH secretion showed in obese patients a median peak of 24·4 µg/l (range 7·4–85·0 µg/l), significantly greater than the response after GHRH (P < 0·05). After the combined administration of GHRH plus ghrelin in obese patients the median peak GH secretion was 39·9 µg/l (range 19·2–120·0 µg/l), significantly greater than the response after GHRH (P < 0·05) or ghrelin (P < 0·05). GHRH‐induced GH secretion in normal control subjects showed a median peak of 25·0 µg/l (range 16·5–33·4 µg/l). Ghrelin‐induced GH secretion in normal showed a median peak of 68·5 µg/l (range 22·5–119·5 µg/l), significantly greater than the response after GHRH (P < 0·05). After the combined administration of GHRH plus ghrelin, in normal subjects the median peak GH secretion was 117·8 µg/l (range 77·5–280·1 µg/l), significantly greater than the response after GHRH or ghrelin alone (P < 0·05). When we compare the response of normal and obese patients, after GHRH alone, it was markedly decreased in obese people when compared with normal patients (P < 0·05) with a median GH peak of 25·0 µg/l (range 16·5–33·4 µg/l) and 2·4 µg/l (range 0·9–8·9 µg/l) for normal and obese patients, respectively. When we compare the response of normal and obese patients, after ghrelin alone or GHRH plus ghrelin, it was only blunted in obese subjects when compared with normal subjects with a median GH peak of 68·5 µg/l (range 22·5–119·5 µg/l) and 24·4 µg/l (range 7·4–85 µg/l) for normal and obese subjects, respectively, after ghrelin alone (P < 0·05) and a median GH peak of 117·8 µg/l (range 77·5–280·1 µg/l) and 39·9 µg/l (range 19·2–120·0 µg/l) for normal and obese patients, respectively, after GHRH plus ghrelin (P < 0·05). conclusions This study has demonstrated a massive GH response to ghrelin alone or combined with GHRH in obese patients, suggesting that altered ghrelin secretion could play a major role in the blunted GH secretion present in obese patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2004.02092.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 54

Metadata

Authors
Alvarez‐Castro, P., Isidro, M. L., Garcia‐Buela, J., Leal‐Cerro, A., Broglio, F., Tassone, F., Ghigo, E., Dieguez, C., Casanueva, F. F., & Cordido, F.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2004-07-26
Volume
61
Issue
2
Pages
250-255
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2087134473
Cited by
54
References
4
FWCI
3.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Marked GH secretion after ghrelin alone or combined with GH‐releasing hormone (GHRH) in obese patients. https://app.cochat.ai/papers/10.1111/j.1365-2265.2004.02092.x
The paper
Alvarez‐Castro, P., Isidro, M. L., Garcia‐Buela, J., Leal‐Cerro, A., Broglio, F., Tassone, F., Ghigo, E., Dieguez, C., Casanueva, F. F., & Cordido, F. (2004). Marked GH secretion after ghrelin alone or combined with GH‐releasing hormone (GHRH) in obese patients. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2004.02092.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.